IAIM
TSHA icon

International Assets Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

International Assets Investment Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
2,000
– – ﹤0.01% 1733
2026
Q1 		$8.62K Hold
2,000
– – ﹤0.01% 1717
2025
Q4 		$11K Buy
+2,000
New +$9.71K ﹤0.01% 1633
2024
Q4 		– Sell
-2,000
Closed -$4.02K – 1857
2024
Q3 		$4.02K Hold
2,000
– – ﹤0.01% 1663
2024
Q2 		$4.48K Buy
+2,000
New +$5.82K ﹤0.01% 1871

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

International Assets Investment Management's TSHA Position: Q2 2026 in Review

International Assets Investment Management held its Taysha Gene Therapies (TSHA) position steady in Q2 2026 at 2,000 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

International Assets Investment Management first reported a position in TSHA in Q2 2024 and has held it in 5 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • International Assets Investment Management held 2,000 shares of Taysha Gene Therapies worth $13.3K as of Q2 2026.
  • International Assets Investment Management left its Taysha Gene Therapies share count unchanged in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1733 holding.
  • International Assets Investment Management first reported a position in Taysha Gene Therapies in Q2 2024 and has held it in 5 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.